MedTrace Logo

Nutritional Supplement Impact on Metabolic Parameters

NCT02349555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2016-09-27

No results posted yet for this study

Summary

This open label study seeks to study the effects of a nutritional supplement on inflammatory markers, metabolic parameters, and safety in subjects compared to baseline after taking supplement for 2 and 4 months.

Conditions

  • Other Endocrine/Nutritional/Metabolic Disorder

Interventions

DIETARY_SUPPLEMENT

Nutritional Supplement Blend

It is to be taken orally at a dose of 4 capsules per day, 2 capsules with breakfast and 2 capsules with dinner.

Sponsors & Collaborators

  • Texas Diabetes & Endocrinology, P.A.

    collaborator OTHER

  • Utah State University

    collaborator OTHER

  • Pharmanex

    lead INDUSTRY

Principal Investigators

  • Thomas Blevins, MD · Founder

  • Michael Lefevre, PhD · Scientific Director

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02349555 on ClinicalTrials.gov